Anesthesia Flashcards
Name (3) forms of opiod receptors that are used by endogenous and exogenous opiods
Name (3) forms of opiod receptors that are used by endogenous and exogenous opiods
1. Mu
2. Delta
3. Kappa
All exogenous opiods activate MOR to produce analgesia
alpha, beta, and gamma endorphins (endogenous opiods) bind to _ receptors
alpha, beta, and gamma endorphins (endogenous opiods) bind to Mu receptors
Enkephalins (endogenous opiods) bind to _ receptors
Enkephalins (endogenous opiods) bind to delta receptors
Dynorphins (endogenous opiods) bind to _ receptors
Dynorphins (endogenous opiods) bind to kappa receptors
Codeine, morphine, hydrocodone, oxycodone, etc are examples of [class drugs]
Codeine, morphine, hydrocodone, oxycodone, tramadol, etc are examples of full MOR agonists
* MOR = mu opiod receptor
Buprenorphine and nalbuphine are exogenous opiods which are [drug class]
Buprenorphine and nalbuphine are exogenous opiods which are partial MOR agonists
Methylnaltrexone is a drug that acts as [drug class]
Methylnaltrexone is a drug that acts as peripherally acting MOR antagonist
* Other PAMORAs include alvimopan, naldemedine, naloxegol, pentazocine
_ and _ are two inverse agonists of MOR
Naloxone and Naltrexone are two inverse agonists of MOR
A drug from [drug category] or [drug category] class would be used for opioid reversal
A drug from neutral antagonist or inverse agonist class would be used for opioid reversal
Inverse MOR agonists are extremely effective becuase they inhibit _
Inverse MOR agonists are extremely effective becuase they inhibit basal MOR activity
* MOR receptors signal in the absence of agonist
* Drugs like naloxone can turn off the agonist-independent signaling and antagonize the natural agonist
Opiods _ the ascending pain pathways and _ descending modulatory pathways
Opiods inhibit the ascending pain pathways and stimulate descending modulatory pathways
Pre-synpatically, opioids act on _ channels
Pre-synpatically, opioids act on Ca2+ channels (inhibiting them)
* This inhibits NT release and transmission of ascending pain signal
Post-synaptically, opioids act on _ channels
Post-synaptically, opioids act on K channels (opening them) –> hyperpolarization
* * This inhibits NT release and transmission of ascending pain signal
Opiods act on the pre-synapse of modulatory pain neurons to _ the release of _ and turn on the modulation
Opiods act on the pre-synapse of modulatory pain neurons to inhibit the release of GABA and turn on the modulation
* They disinhibit the descending modulatory pathway
Opioids act on the _ synapse to essentially stimulate the descending modulatory pathway and induce analgesia
Opioids act on the presynapse to essentially stimulate the descending modulatory pathway and induce analgesia
The glucuronidated forms of many opioids have slower _ and longer _
The glucuronidated forms of many opioids have slower renal clearance and longer durations of action
[Opioid] gets converted into morphine
Codeine gets converted into morphine
* Morphine and its derivatives can be neurotoxic
All opioids can cause _ and _ as CNS toxicities
All opioids can cause sedation and respiratory depression as CNS toxicities
* This is ultimately what causes opioid overdose death
Because Mu receptors are found all throughout the GIT, opioids can cause [toxicity]
Because Mu receptors are found all throughout the GIT, opioids can cause constipation
* We inhibit neuron firing in the gut and slow GI motility
[Drug class] can be used to treat opioid induced constipation
Peripherally acting mu opioid receptor antagonist (PAMORAs) can be used to treat opioid induced constipation
* They do not cross the BBB to interfere with opioid analgesia
Because opioids inhibit GABA release to turn on the descending modulatory pathway, they additionally induce [toxicity]
Because opioids inhibit GABA release to turn on the descending modulatory pathway, they additionally induce dopamine release
* Increase DA release into the nucleus accumbens via the mesolimbic pathway –> addiction
_ is a good drug option for patients with opioid addiction because its properties treat physical and psychological dependence
Buprenorphine is a good drug option for patients with opioid addiction because its properties treat physical and psychological dependence
Buprenorphine is (more/less) potent than a full MOR agonist
Buprenorphine is more potent than a full MOR agonist
* Although it is less effective, it is more potent so it outcompetes any full agonist that may be co-administered
NSAID works as an anti-inflammatory, non-opioid analgesic via [receptor action] and [downstream effect]
NSAID works as an anti-inflammatory, non-opioid analgesic via inhibiting COX-2 receptors and blocking prostaglandin synthesis
* Most are non-selective and block COX-1 and COX-2
_ and _ are the prostaglandins that mediate pain receptors
PGE2 and PGF2a are the prostaglandins that mediate pain receptors
? –> COX –> prostaglandins
Arachidonic acid –> COX –> prostaglandins
[COX receptor] is constitutive while [COX receptor] is induced
COX-1 is constitutive while COX-2 is induced
* Meaning COX-1 is always on in the background for homeostatic functions while COX-2 is only used for inflammatory functions when necessary (pain, fever, etc)
_ is the only “selective” NSAID on the market
Celecoxib is the only “selective” NSAID on the market
* Specific to COX-2
_ and _ are two important prostaglandins that act as vasodilators (especially important in the kidney)
PGE2 and PGI2 are two important prostaglandins that act as vasodilators (especially important in the kidney)
NSAIDs can lead to hypertension via [mechanism (hint kidneys)]
NSAIDs can lead to hypertension via reducing GFR –> decreasing Na+/ H2O excretion –> increased blood volume
COX-1 inhibition leads to [toxicity]
COX-1 inhibition leads to inhibition of gastric mucus production
* Increases risk of upper and lower GI bleeding
Non-aspirin NSAIDs may increase clotting risk due to preferential inhibition of [prostaglandin] synthesis (which normally inhibits platelet activation)
Non-aspirin NSAIDs may increase clotting risk due to preferential inhibition of PGI2 synthesis (which normally inhibits platelet activation)
Aspirin preferentially blocks [prostaglandin] which normally promotes platelet activation
Aspirin preferentially blocks thromboxane A2 which normally promotes platelet activation
* Therefore it can lower MI and stroke risk